Breaking News Instant updates and real-time market news.

JNJ

Johnson & Johnson

$129.76

-0.04 (-0.03%)

17:02
01/11/19
01/11
17:02
01/11/19
17:02

Johnson & Johnson urges holders to reject 'mini-tender offer by Peer & Peri

Johnson & Johnson received notice of an unsolicited "mini-tender" offer by Peer & Peri LLC to purchase up to 30,000 shares of common stock of Johnson & Johnson, representing approximately 0.001% of the company's outstanding shares. Peer & Peri's offer price of $98.50 per share in cash is approximately 22.6% lower than the $127.27 closing price of Johnson & Johnson shares on December 28, 2018, the last closing price prior to commencement of the mini-tender offer. Johnson & Johnson said it does not endorse Peer & Peri's unsolicited below-market mini-tender offer and recommends that shareholders do not tender their shares because the offer is at a price "significantly below the current market price of Johnson & Johnson shares." Johnson & Johnson recommends that shareholders who have not responded to Peer & Peri's offer take no action. Johnson & Johnson also recommends that shareholders who have already tendered their shares withdraw those shares in accordance with Peer & Peri's offering documents prior to the expiration of the offer. The offer is currently scheduled to expire at 5 p.m. New York City time on January 31, 2019. Johnson & Johnson said it is not affiliated or associated in any way with Peer & Peri, its mini-tender offer or the offer documentation. Johnson & Johnson urges shareholders to obtain current market quotations for their shares, to consult with their broker or financial advisor, and to exercise caution with respect to Peer & Peri's mini-tender offer.

  • 22

    Jan

  • 27

    Jan

  • 18

    Feb

JNJ Johnson & Johnson
$129.76

-0.04 (-0.03%)

12/20/18
WELS
12/20/18
NO CHANGE
WELS
Outperform
No change in talc litigation risk for Johnson & Johnson, says Wells Fargo
Wells Fargo analyst Larry Biegelsen notes that the NY Times reported that Johnson & Johnson has lost its bid to overturn the $4.7B in a talc trial in St. Louis in July 2018. After checking with the company, the analyst is "able to confirm" that the decision relates to the trial judge denying Johnson & Johnson's post trial motion to set aside the $4.7B verdict. Biegelsen understands that the company had to file this motion in order to file its actual appeal of the decision with the appellate court. As such, he believes the judge's decision should not materially affect the overall talc situation for Johnson & Johnson. Wells Fargo has an Outperform rating on the shares.
01/02/19
SBSH
01/02/19
NO CHANGE
SBSH
Citi makes four rating changes in Medical Devices, 'warning up' to J&J
Citi analyst Amit Hazan issued his 2019 preview for Medical Devices, which included four rating changes. The analyst upgraded both Zimmer Biomet (ZBH) and Baxter International (BAX) to Buy from Neutral, downgraded Medtronic (MDT) to Neutral from Buy and downgraded Abbott Laboratories (ABT) to Sell from Neutral. He also kept Buy ratings on Intuitive Surgical (ISRG) and Boston Scientific (BSX), but adds he's "relatively more cautious." Further, Hazan kept a Sell rating on Edwards Lifesciences (EW) and says he's "warming up" to Neutral-rated Johnson & Johnson (JNJ). The analyst expects "fairly stable" fundamentals for the group in 2019, with "modest slowdowns" in organic sales and earnings growth.
01/04/19
CANT
01/04/19
NO CHANGE
Target $100
CANT
Overweight
Cantor Fitzgerald analysis suggests others could bid for Celgene
Cantor Fitzgerald analyst Alethia Young reiterates an Overweight rating on Celgene (CELG) with a $100 price target after the company reached an agreement to be acquired by Bristol-Myers Squibb (BMY). Bristol "likely got a good deal, although Celgene has intellectual property and pipeline uncertainties that are key moving pieces," Young tells investors in a research note. Her estimated net present value for Celgene is $80B, assuming some cost synergies, versus the $74B equity valuation in the Bristol deal, excluding the contingent value rights. Young's analysis indicates that companies like Amgen (AMGN) and Johnson & Johnson (JNJ) "could potentially achieve greater commercial synergies." However, the analyst thinks Celgene shareholders "may be satisfied with the current deal after quite a roller-coaster over the past 18 months."
01/04/19
BTIG
01/04/19
NO CHANGE
Target $17
BTIG
Buy
Veracyte price target raised to $17 from $15 at BTIG
BTIG analyst Sung Ji Nam raised his price target on Veracyte (VCYT) to $17 and kept the Buy rating on the shares after its announced long term partnership with Johnson & Johnson (JNJ) yesterday. The analyst says the collaboration aims to accelerate the development of the first nasal swab test for early lung cancer detection and involve the two companies sharing existing data and samples from clinical studies. Sung Ji Nam states that the deal should lead to acceleration of next -gen Percepta launch, adding that the nasal swab test development could quadruple the company's total addressable market value in the U.S. alone.

TODAY'S FREE FLY STORIES

03:00
01/17/19
01/17
03:00
01/17/19
03:00
General news
FX Update: An abatement in risk appetite has impacted currencies »

FX Update: An abatement…

01:50
01/17/19
01/17
01:50
01/17/19
01:50
General news
Asian Market Wrap: »

Asian Market Wrap:…

RVNC

Revance

$18.11

-2.11 (-10.44%)

21:05
01/16/19
01/16
21:05
01/16/19
21:05
Syndicate
Revance 5.9M share Secondary priced at $17.00 »

Goldman Sachs, Cowen and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jan

MRTX

Mirati Therapeutics

$62.51

-2.33 (-3.59%)

20:49
01/16/19
01/16
20:49
01/16/19
20:49
Syndicate
Mirati Therapeutics 1.6M share Spot Secondary priced at $62.00 »

The deal priced at the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jan

BREW

Craft Brew

$15.50

0.19 (1.24%)

20:45
01/16/19
01/16
20:45
01/16/19
20:45
Initiation
Craft Brew initiated at Maxim »

Craft Brew initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ROX

Castle Brands

$0.91

0.0122 (1.36%)

20:41
01/16/19
01/16
20:41
01/16/19
20:41
Initiation
Castle Brands initiated at Maxim »

Castle Brands initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PRT

PermRock Royalty Trust

$9.61

-0.39 (-3.90%)

20:39
01/16/19
01/16
20:39
01/16/19
20:39
Downgrade
PermRock Royalty Trust rating change at Stifel »

PermRock Royalty Trust…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GBCI

Glacier Bancorp

$42.87

1.36 (3.28%)

20:38
01/16/19
01/16
20:38
01/16/19
20:38
Hot Stocks
Glacier Bancorp acquires FNB Bancorp »

Glacier Bancorp announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Feb

  • 26

    Feb

  • 27

    Feb

  • 12

    Mar

ERJ

Embraer

$22.81

-0.59 (-2.52%)

20:34
01/16/19
01/16
20:34
01/16/19
20:34
Downgrade
Embraer rating change at Morgan Stanley »

Embraer downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AICAF

Air China

$0.00

(0.00%)

20:32
01/16/19
01/16
20:32
01/16/19
20:32
Upgrade
Air China rating change at HSBC »

Air China upgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CEA

China Eastern Airlines

$28.64

-0.09 (-0.31%)

20:26
01/16/19
01/16
20:26
01/16/19
20:26
Upgrade
China Eastern Airlines rating change at HSBC »

China Eastern Airlines…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MS

Morgan Stanley

$44.48

1.59 (3.71%)

, BBT

BB&T

$47.55

1.2 (2.59%)

20:25
01/16/19
01/16
20:25
01/16/19
20:25
Earnings
Notable companies reporting before tomorrow's open »

Notable companies…

MS

Morgan Stanley

$44.48

1.59 (3.71%)

BBT

BB&T

$47.55

1.2 (2.59%)

PPG

PPG

$102.58

1.58 (1.56%)

MTB

M&T Bank

$154.45

3.04 (2.01%)

KEY

KeyCorp

$16.75

0.44 (2.70%)

FAST

Fastenal

$54.11

-0.47 (-0.86%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jan

  • 17

    Jan

  • 17

    Jan

  • 17

    Jan

  • 17

    Jan

  • 17

    Jan

  • 11

    Feb

  • 23

    May

  • 18

    Oct

FDC

First Data

$21.27

3.72 (21.20%)

20:07
01/16/19
01/16
20:07
01/16/19
20:07
Downgrade
First Data rating change at Goldman Sachs »

First Data downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Mar

VEON

Veon

$2.56

-0.03 (-1.16%)

19:44
01/16/19
01/16
19:44
01/16/19
19:44
Downgrade
Veon rating change at VTB Capital »

Veon downgraded to Hold…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMZN

Amazon.com

$1,682.84

7.84 (0.47%)

19:22
01/16/19
01/16
19:22
01/16/19
19:22
Hot Stocks
Amazon announces AWS Backup service »

Amazon Web Service, an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Jan

  • 28

    Jan

  • 20

    Feb

  • 03

    Mar

GS

Goldman Sachs

$197.03

17.12 (9.52%)

19:09
01/16/19
01/16
19:09
01/16/19
19:09
Periodicals
WSJ's "Heard on the Street" column says to look past Goldman Sachs Q4 glitter »

The Wall Street…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Mar

TSLA

Tesla

$346.03

1.78 (0.52%)

18:57
01/16/19
01/16
18:57
01/16/19
18:57
Periodicals
CA makes up large portion of Tesla Model 3 registrations in 2018, Bloomberg says »

The state of California…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Jan

CARS

Cars.com

$23.14

-0.26 (-1.11%)

, MNKD

MannKind

$1.32

-0.06 (-4.35%)

18:46
01/16/19
01/16
18:46
01/16/19
18:46
Hot Stocks
Fly Intel: After Hours Movers »

HIGHER: Cars.com (CARS)…

CARS

Cars.com

$23.14

-0.26 (-1.11%)

MNKD

MannKind

$1.32

-0.06 (-4.35%)

FOLD

Amicus

$12.18

0.19 (1.58%)

FUL

H.B. Fuller

$43.35

0.09 (0.21%)

PLXS

Plexus

$54.88

1.195 (2.23%)

CSX

CSX

$65.36

0.27 (0.41%)

KMI

Kinder Morgan

$17.46

0.15 (0.87%)

AA

Alcoa

$29.02

0.13 (0.45%)

ACB

Aurora Cannabis

$7.33

0.35 (5.01%)

MRTX

Mirati Therapeutics

$62.51

-2.33 (-3.59%)

AAPL

Apple

$154.88

1.84 (1.20%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Jan

  • 16

    Jan

  • 16

    Jan

  • 17

    Jan

  • 17

    Jan

  • 29

    Jan

  • 29

    Jan

  • 10

    Feb

  • 11

    Feb

  • 26

    Feb

  • 27

    Feb

  • 28

    May

  • 17

    Jan

BAC

Bank of America

$28.44

1.89 (7.12%)

18:46
01/16/19
01/16
18:46
01/16/19
18:46
Periodicals
BofA's global investment banking head to leave bank, FT reports »

Bank of America's…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Jan

  • 12

    Feb

  • 03

    Mar

NEWR

New Relic

$90.47

1.38 (1.55%)

18:44
01/16/19
01/16
18:44
01/16/19
18:44
Hot Stocks
New Relic CEO: 'We are an app-centric company' »

In an interview on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

  • 24

    Jan

  • 25

    Jan

  • 06

    Feb

  • 25

    Feb

  • 14

    Mar

TME

Tencent Music

$12.99

0.57 (4.59%)

18:33
01/16/19
01/16
18:33
01/16/19
18:33
Initiation
Tencent Music initiated at JPMorgan »

Tencent Music initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ASCMA

Ascent Capital

$0.40

-0.0499 (-11.09%)

18:27
01/16/19
01/16
18:27
01/16/19
18:27
Hot Stocks
Ascent Capital announces strategic review »

Ascent Capital Group…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CMS

CMS Energy

$50.56

0.34 (0.68%)

18:19
01/16/19
01/16
18:19
01/16/19
18:19
Initiation
CMS Energy initiated at Goldman Sachs »

CMS Energy initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Feb

DTE

DTE Energy

$111.73

0.48 (0.43%)

18:15
01/16/19
01/16
18:15
01/16/19
18:15
Initiation
DTE Energy initiated at Goldman Sachs »

DTE Energy initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

18:15
01/16/19
01/16
18:15
01/16/19
18:15
General news
Breaking General news story  »

Minneapolis Federal…

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.